Multiplexed single-cell transcriptomics reveals diverse phenotypic outcomes for pathogenic SHP2 variants
Ontology highlight
ABSTRACT: The protein tyrosine phosphatase SHP2, encoded by PTPN11, is an important regulator of Ras/MAPK signaling and a signaling hub downstream of receptor tyrosine kinases and other transmembrane receptors. Germline missense PTPN11 mutations cause developmental disorders such as Noonan Syndrome, whereas somatic mutations drive diverse cancers. While many pathogenic mutations enhance SHP2 catalytic activity, some are inactivating or alter protein-protein interactions, confounding our understanding of how SHP2 dysregulation causes diseases. Here, we perform multiplexed single-cell transcriptional profiling in cells expressing clinically diverse SHP2 variants, with and without receptor tyrosine kinase stimulation. We find that loss of catalytic activity does not phenocopy SHP2 knock-out at the gene expression level, and we show evidence for both convergent phenotypic effects from mechanistically distinct mutations, as well as the divergent effects from structurally similar mutations. These findings provide a framework for understanding how structural perturbations to SHP2 impact cellular outcomes.
ORGANISM(S): Homo sapiens
PROVIDER: GSE300865 | GEO | 2025/07/02
REPOSITORIES: GEO
ACCESS DATA